PROCEPT BioRobotics Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
PROCEPT BioRobotics Corporation (PRCT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $6.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-02-26
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-03-31 was $1.00M, a 9.09% decline year-over-year.
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2021-12-31 was $1.00M, a 150.00% increase year-over-year.
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2021-03-31 was $1.10M.
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2020-12-31 was $400.00K.
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $6.20M, a 10.71% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $5.60M, a 3.45% decline from fiscal 2023.
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $5.80M, a 20.83% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $4.80M, a 41.18% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $6.20M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $5.60M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $5.80M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $4.80M 10-K · filed 2024-02-28 | |||
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-06 | $2.00M derived: sum of 2 quarters · filed 2023-02-28 | ||
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.40M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $2.40M 10-Q · filed 2021-11-05 | |||
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-06 | $1.50M derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.60M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $1.20M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |